Search Results 231-240 of 16372 for monoclonal antibody

  1. A Randomized, Open-label Two-arm Phase III Comparative Study Assessing the Role of Involved Mediastinal Radiotherapy after Rituximab Containing Chemotherapy Regimens to Patients With Newly Diagnosed Primary Mediastinal Large B-Cell Lymphoma - Mayo Clinic

    Primary mediastinal large B cell lymphoma is treated with a combination of chemotherapy and the monoclonal antibody rituximab (chemoimmunotherapy).

  2. Rituximab-pvvr (intravenous route) - Mayo Clinic

    Rituximab-pvvr is a monoclonal antibody. Rituximab-pvvr injection is also used together with other cancer medicines (eg, fludarabine and cyclophosphamide) ...

  3. Pembrolizumab (intravenous route) - Mayo Clinic

    Pembrolizumab is a monoclonal antibody that changes the immune system to help control the growth of cancer cells. This medicine is to be given only by or ...

  4. Study of SC-003 in Subjects With Platinum-Resistant/Refractory Ovarian Cancer - Mayo Clinic

    SC-003 is an antibody-drug conjugate (ADC) comprised of a monoclonal antibody linked to a potent chemotherapy. Participation eligibility. Participant ...

  5. Clinical trials - Oncology (Medical)

    Monoclonal antibodies, such ... Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin.

  6. Otolaryngology (ENT)/Head and Neck Surgery - Clinical trials

    Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...

  7. A Study of Copanlisib and Nivolumab in Treating Participants With Recurrent or Refractory Diffuse Large B-cell Lymphoma or Primary Mediastinal Large B-cell Lymphoma - Mayo Clinic

    Copanlisib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as nivolumab, may interfere ...

  8. Translational Neuro-Oncology: Jann N. Sarkaria - Research Projects

    ADC biology. One promising novel therapeutic approach uses antibody-drug conjugates (ADC). ADCs combine monoclonal antibodies and cytotoxic payloads to target ...

  9. Treatment of recurrent CDI: Examining the efficacy and safety of standardized live biotherapeutics as microbiota restoration therapies - Mayo Clinic

    ... monoclonal antibody that binds to toxin-B for the prevention of recurrences. Because neither standard-of-care antibiotics nor bezlotoxumab repairs the ...

  10. Maria Alice V. Willrich, Ph.D. - Doctors and Medical Staff - Mayo Clinic

    Expertise in monoclonal antibody therapies monitoring using laboratory tests · Monoclonal gammopathies laboratory testing using routine and novel mass ...